ATLASCollPlant Biotechnologies (CLGN) earnings date: Nov 25, 2026
CollPlant Biotechnologies (CLGN) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 25, 2026, after the close. Analysts expect EPS of -$0.50.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CLGN
| Last price | $4.05 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.8% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 6 reports |
These figures come from the same calibrated model and valuation as the CollPlant Biotechnologies stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
CollPlant Biotechnologies reports on Nov 25, 2026. One email the day before, with ATLAS’s read on CollPlant Biotechnologies. You can switch it off at any time.
Alert me before CLGN reportsFree to start. Creating an account takes under a minute.
Notify me when CollPlant Biotechnologies reports
Track CLGN free Add CollPlant Biotechnologies to a free ATLAS watchlist and see its next report date in one place.
CLGN earnings at a glance
| Next report (confirmed) | Wed, Nov 25, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.50 |
| Last report | Sep 30, 2026 · Beat |
| Beat rate (last 6 reports) | 4 of 6 (67%) |
| Average EPS surprise | -30.0% |
| Average move around a report | ±5.0% (last 5) |
| Sector | Healthcare · Biotechnology |
CollPlant Biotechnologies earnings history: last 6 reports
CollPlant Biotechnologies last reported on Sep 30, 2026: EPS of -$1.89 against an estimate of -$2.40 (+21.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 30, 2026 | -$2.40 | -$1.89 | +21.3% | Beat | – |
| Jul 16, 2026 | $1.10 | $1.17 | +6.4% | Beat | -4.0% |
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | 0.0% |
| Mar 26, 2026 | -$1.90 | -$2.50 | -31.6% | Miss | -16.8% |
| Nov 26, 2025 | $1.55 | -$2.70 | -274.2% | Miss | -2.3% |
| Sep 23, 2025 | $1.23 | $2.36 | +91.9% | Beat | +1.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CLGN
See the fair value, the probability range and the earnings history of CollPlant Biotechnologies on its ATLAS page.
CollPlant Biotechnologies (CLGN) stock analysisPlans from €3.99 a month.
CollPlant Biotechnologies earnings: frequently asked questions
When does CollPlant Biotechnologies (CLGN) report earnings?
CollPlant Biotechnologies is scheduled to report on Wednesday, November 25, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CLGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.50 per share (USD). Estimates can change before the report.
How often does CLGN beat earnings estimates?
Of its last 6 reports with a recorded result, CollPlant Biotechnologies beat the EPS estimate 4 times; the average surprise was -30.0%. Past results do not predict the next one.
How much does CLGN move around earnings?
Over its last 5 reports the stock moved an average of 5.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did CollPlant Biotechnologies beat earnings estimates last quarter?
CollPlant Biotechnologies last reported on Sep 30, 2026: EPS of -$1.89 against an estimate of -$2.40 (+21.3% surprise), a beat.
How much does CLGN usually move in a day?
On a normal trading day the ATLAS model puts CLGN’s one-day range at about ±5.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 25, 2026
Educational information, not investment advice. Disclaimer